Background Magnesium sulphate is a common therapy in perinatal care. Its benefits when
given to women at risk of preterm birth for fetal neuroprotection (prevention of cerebral palsy …

Objective The objective is to provide guidelines for the use of antenatal magnesium sulphate
for fetal neuroprotection of the preterm infant. Options Antenatal magnesium sulphate …

Introduction To evaluate the effect of antenatal magnesium sulfate (MgSO4) on mortality and
morbidity outcomes related to the gastrointestinal system (GI) in preterm infants. Methods …

Background: The underlying neuro-protective mechanisms of antenatal magnesium sulfate
(MgSO 4) in infants born preterm remain poorly understood. Early neonatal brain injury may …

Objective Antenatal magnesium (anteMg) is used for various obstetric indications including
fetal neuroprotection. Infants exposed to anteMg may be at risk for respiratory depression …

Objective This study aims to investigate the effects of antenatal magnesium sulfate on
intestinal blood flow in preterm neonates. Study Design In this prospective case–match …

Abstract Introduction: Magnesium sulfate (MgSO4) is frequently administered for maternal
and fetal neuroprotection in preeclampsia (PE) and imminent preterm birth, respectively …

Objective The use of antenatal magnesium sulfate (MgSO 4) has been associated with
neuroprotective effects. One of its' proposed mechanisms of action includes antagonism of …

Optimal fluid management of preterm babies with suspected or confirmed diagnosis of
patent ductus arteriosus (PDA) is frequently challenging for neonatal care physician …

Background: Antenatal magnesium sulphate (MgSO4) therapy given to women at risk of
preterm birth reduced the risk of cerebral palsy in early childhood. However, its effect on …